Literature DB >> 17091526

Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV.

Christoph Boss1, Olivier Corminboeuf, Corinna Grisostomi, Solange Meyer, Andrew F Jones, Lars Prade, Christoph Binkert, Walter Fischli, Thomas Weller, Daniel Bur.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17091526     DOI： 10.1002/cmdc.200600223

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  7 in total

Review 1.  Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria.

Authors:  Rodrigo G Ducati; Hilda A Namanja-Magliano; Vern L Schramm
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

Review 2.  Structural studies of vacuolar plasmepsins.

Authors:  Prasenjit Bhaumik; Alla Gustchina; Alexander Wlodawer
Journal:  Biochim Biophys Acta       Date:  2011-04-20

3.  Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum.

Authors:  Prasenjit Bhaumik; Huogen Xiao; Charity L Parr; Yoshiaki Kiso; Alla Gustchina; Rickey Y Yada; Alexander Wlodawer
Journal:  J Mol Biol       Date:  2009-03-11       Impact factor: 5.469

Review 4.  The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.

Authors:  Ifedayo Victor Ogungbe; William N Setzer
Journal:  Molecules       Date:  2016-10-19       Impact factor: 4.411

5.  EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology.

Authors:  Philip Brennecke; Dace Rasina; Oscar Aubi; Katja Herzog; Johannes Landskron; Bastien Cautain; Francisca Vicente; Jordi Quintana; Jordi Mestres; Bahne Stechmann; Bernhard Ellinger; Jose Brea; Jacek L Kolanowski; Radosław Pilarski; Mar Orzaez; Antonio Pineda-Lucena; Luca Laraia; Faranak Nami; Piotr Zielenkiewicz; Kamil Paruch; Espen Hansen; Jens P von Kries; Martin Neuenschwander; Edgar Specker; Petr Bartunek; Sarka Simova; Zbigniew Leśnikowski; Stefan Krauss; Lari Lehtiö; Ursula Bilitewski; Mark Brönstrup; Kjetil Taskén; Aigars Jirgensons; Heiko Lickert; Mads H Clausen; Jeanette H Andersen; Maria J Vicent; Olga Genilloud; Aurora Martinez; Marc Nazaré; Wolfgang Fecke; Philip Gribbon
Journal:  SLAS Discov       Date:  2019-01-07       Impact factor: 3.341

6.  Potential repurposing of four FDA approved compounds with antiplasmodial activity identified through proteome scale computational drug discovery and in vitro assay.

Authors:  Bakary N'tji Diallo; Tarryn Swart; Heinrich C Hoppe; Özlem Tastan Bishop; Kevin Lobb
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

Review 7.  Pepsin-like aspartic proteases (PAPs) as model systems for combining biomolecular simulation with biophysical experiments.

Authors:  Soumendranath Bhakat
Journal:  RSC Adv       Date:  2021-03-17       Impact factor: 3.361
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.